EDOG Institut de Cancerologie de l'Ouest

Nantes, Loir-Atlantique 44000

0 studies enrolling now · 1 studies all time

What they study most

Solid Tumor

Studies at this site

• A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types — Recruiting now